AzTrials
AzTrials

Postoperative PainNCT05728892

Melatonin and Its Effect on the Perioperative Opioid Needs in Pediatric Patients Undergoing Laparoscopic Surgery.

A study testing Melatonin 3 MG in people with Postoperative Pain, run by Ain Shams University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To study the role of Preoperative Melatonin adminsteration in pediatric patients undergoing laparoscopic surgeries regarding its analgesic and sedative effects Read more about this study

Who is it for?
Ages 2 to 10 yearsHealthy volunteers can take part
Conditions the study is for
Postoperative Pain
What is being tested?
Melatonin 3 MG
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
72 participants
Where
1 siteEgypt
Study dates
25 Jan 2023to 30 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Age from 2 to 10 years.
  • Sex: Both sexes.
  • Patients with ASA classificaion I and II.

Who cannot join

  • Declining to give written informed consent.
  • History of allergy to the medications used in the study.
  • psychiatric disorder.
  • ASA classification III-V.
  • Fever ,cough , asthma or upper respiratory tract infection, neuromuscular disorders, spine abnormalities.
  • Anticipated difficult airway .
  • History of malignant hyperthermia

Trial locations and contacts

1 site in 1 country.

Mohamed A Tolba, MD contact

01156622298

Mohamedtolba@med.asu.edu.eg

Diaaeldein M Haiba contact

01006516286

Egypt1 site, 1 recruiting
  • Ain shams university hospital

    Cairo, Abbasia, 11213

    Sherif Wadei, MD, 01156622298

    Recruiting

Other trials in Egypt

About this study

To study the role of Preoperative Melatonin adminsteration in pediatric patients undergoing laparoscopic surgeries regarding its analgesic and sedative effects

Being tested
Melatonin 3 MG, Placebo
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Melatonin 3 MGDrug

    Preopertive melatonin adminstration oral 0.2 mg /kg 45 min before general anaethesia.

  • PlaceboOther

    Placebo medication will be given to control group

Study groups in NCT05728892
Study groupRoleWhat they receive
Group AActive comparatorpatients undergoing abdominal surgery receiving melatonin
Receives: Drug: Melatonin 3 MG
Group BPlacebo comparatorcontrol group
Receives: Other: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain

    Assesment of pain will be done using Face, Leg, Activity , Crying and Consolability behavioural pain scale (FLACC), Each category is scored on the 0-2 scale, which results in a total score of 0-10.

    0 = Relaxed and comfortable, 1-3 = Mild discomfort, 4-6 = Moderate pain and 7-10 = Severe discomfort or pain or both.

    Measured: Discharge from postanesthesia care unit (1 hour)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2023
  2. Study start25 Jan 2023
  3. Primary completion30 Dec 2024 (estimated)
  4. Study completion30 May 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05728892
Sponsor's protocol ID
FAMSU R264/2022
Status last verified
Feb 2024
First submitted
26 Jan 2023
Last updated
27 Aug 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Melatonin 3 MG in people with Postoperative Pain, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mohamed A Tolba, MD (01156622298, Mohamedtolba@med.asu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain (time frame: Discharge from postanesthesia care unit (1 hour)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in